Life Sciences

At Tetragon Life Sciences, we leverage over 15 years of life sciences investing experience to advance the next generation of healthcare innovation. Our purpose-built team combines rigorous diligence, market insight, and scientific expertise to unlock value across the life sciences landscape.

We invest in both public and private markets, targeting opportunities throughout the drug development lifecycle – from late pre-clinical to early commercial stages.

Our fundamentals-driven approach rigorously assesses both scientific merit and commercial potential, drawing on our team’s multidisciplinary expertise in genetics, biology, chemistry, clinical trial design, biostatistics, regulatory affairs and commercial analyses.

Our investment strategy is focused on high-impact therapeutic areas such as immune-mediated diseases, cardiometabolic and renal conditions, neurological disorders, rare diseases and precision oncology. We work across a range of modalities, including biologics, oligonucleotides and small molecules and seek opportunities at key development stages where innovation and value creation intersect.